Mitsuko Ideno

Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer

Naoyuki Sakamoto, Takeshi Ishikawa, Satoshi Kokura et al. · Journal of Translational Medicine · 2015 · 266 citations · Full text

Pharmacy, Immunology, Oncology +17

Phase <scp>I</scp> clinical trial of adoptive transfer of expanded natural killer cells in combination with <scp>I</scp>g<scp>G</scp>1 antibody in patients with gastric or colorectal cancer

Takeshi Ishikawa, Tetsuya Okayama, Naoyuki Sakamoto et al. · International Journal of Cancer · 2018 · 107 citations · Full text

Medicine, Immunology, Oncology +17

Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte

Ikuei Nukaya, Masazumi Yasumoto, Tomoko Iwasaki et al. · International Journal of Cancer · 1999 · 100 citations

Life Sciences, Immunology, Oncology +17

Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen

Tsuyoshi Itoh, Yuji Ueda, Ichiro Kawashima et al. · Cancer Immunology Immunotherapy · 2002 · 81 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I Clinical Trial of Fibronectin CH296-Stimulated T Cell Therapy in Patients with Advanced Cancer

Takeshi Ishikawa, Satoshi Kokura, Tatsuji Enoki et al. · PLoS ONE · 2014 · 24 citations · Full text

Medicine, Immunology, Oncology +16